LEADER 03530nam 2200709Ia 450 001 9910960106403321 005 20251017110111.0 010 $a9786610179947 010 $a9780309168106 010 $a0309168104 010 $a9781280179945 010 $a1280179945 010 $a9780309526784 010 $a0309526787 035 $a(CKB)111069351132888 035 $a(SSID)ssj0000200600 035 $a(PQKBManifestationID)11184118 035 $a(PQKBTitleCode)TC0000200600 035 $a(PQKBWorkID)10221531 035 $a(PQKB)10535140 035 $a(MiAaPQ)EBC3375838 035 $a(Au-PeEL)EBL3375838 035 $a(CaPaEBR)ebr10046888 035 $a(CaONFJC)MIL17994 035 $a(OCoLC)53989964 035 $a(Perlego)4735243 035 $a(DNLM)1191211 035 $a(BIP)10837611 035 $a(EXLCZ)99111069351132888 100 $a20040211d2003 my 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMedicare coverage of routine screening for thyroid dysfunction /$fMarc B. Stone and Robert B. Wallace, editors ; Committee on Medicare Coverage of Routine Thyroid Screening, Board on Health Care Services, Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Pres$dc2003 215 $a135 p 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9780309088855 311 08$a0309088852 320 $aIncludes bibliographical references. 327 $a1. Introduction -- 2. Pathophysiology and diagnosis of thyroid disease -- 3. Prevelance and consequences of thyroid dysfuntion -- 4. Screening for thyroid dysfuntion -- 5. The cost of coverage -- 6. Conclusions and recommendations. 330 $aWhen the Medicare program was established in 1965, it was viewed as a form of financial protection for the elderly against catastrophic medical expenses, primarily those related to hospitalization for unexpected illnesses. The first expansions to the program increased the eligible population from the retired to the disabled and to persons receiving chronic renal dialysis. It was not until 1980 that an expansion of services beyond those required "for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member" was included in Medicare. These services, known as preventive services, are intended either to prevent disease (by vaccination) or to detect disease (by diagnostic test) before the symptoms of illness appear. A Committee was formed "to conduct a study on the addition of coverage of routine thyroid screening using a thyroid stimulating hormone test as a preventive benefit provided to Medicare beneficiaries under Title XVIII of the Social Security Act for some or all Medicare beneficiaries." 606 $aThyroid gland$xDiseases 606 $aMedical screening$zUnited States 606 $aMedicare 615 0$aThyroid gland$xDiseases. 615 0$aMedical screening 615 0$aMedicare. 676 $a616.4/4075 701 $aStone$b Marc B$01805823 701 $aWallace$b Robert B.$f1942-$01797965 712 02$aInstitute of Medicine (U.S.).$bCommittee on Medicare Coverage of Routine Thyroid Screening. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910960106403321 996 $aMedicare coverage of routine screening for thyroid dysfunction$94354642 997 $aUNINA